Form D · Other Investment Fund
Life Sciences Innovation Fund II, L.P.
New York, NY · CIK 0001870508
Offering snapshot reported Jul 20, 2023 · SEC filing
- Reported sold
- $10.8M Indefinite offering
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 17, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 20, 2023 | Amendment | $10,808,755 | $0vs Jul 16, 2021 | 38 | SEC filing |
| Jul 16, 2021 | Initial | $10,808,755 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-406537
The Issuer may from time to time elect to engage third party broker dealers. Any commissions and/or expenses paid to such broker dealers will be paid by the General Partner out of net profits.
Source: Form D, filed Jul 20, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
LIFE SCIENCES INNOVATION FUND II, L.P.
Investment adviser: AWM INVESTMENT COMPANY INC
- Gross asset value
- $4.58M
- Beneficial owners
- 36
- ADV minimum commitment
- $100K
Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
Provider details
- Annual audit
- Yes
- Prime brokers
- No
- Custodians
- Yes
- Administrator other than the adviser
- No
- External marketing
- No
ANCHIN, BLOCK AND ANCHIN
PCAOB 168
Filing source
Form ADV 2082851 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-7148827750
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Awm Investment Company, Inc. | Executive |
| David M Greenhouse | Director, Executive |
| Life Sciences Innovation Gp Llc | Director, Executive |
| Austin W Marxe | Director, Executive |
| David Sable | Director, Executive |
| Adam Stettner | Director, Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:New York, NY, 10022